Polymorphism in “ectoenzyme nucleotide pyrophosphate phosphodiesterase 1” (ENPP1 or PC1) and in “insulin receptor substrate-1” (IRS1) genes, which are related to insulin resistance, have also been described in NAFLD patients [14]. This evidence concerns the gene ENPP1 and metabolic dysfunction-associated steatotic liver disease.